Lapatinib and Epirubicin in Treating Patients With Metastatic Breast Cancer. ICORG 06-30
Status: COMPLETED
Study type: INTERVENTIONAL
Conditions: Breast Cancer
Interventions: DRUG: epirubicin hydrochloride|DRUG: lapatinib ditosylate|OTHER: biomarker analysis|OTHER: immunohistochemistry staining method|OTHER: liquid chromatography|OTHER: mass spectrometry
Sponsor: Cancer Trials Ireland